April 9 (Reuters) - A U.S. district court has entered into what is known as a consent decree to restrict the production and sale of Philips' new sleep apnea machines and other devices at several facilities in the country until certain requirements are met, the U.S. Food and Drug Administration said on Tuesday. (Reporting by Christy Santhosh; Editing by Maju Samuel)
Market Closed -
Other stock markets
|
After market 02:06:59 pm | |||
25.54 EUR | +29.35% | 25.35 | -0.74% |
07:48pm | ROYAL PHILIPS : The Dutch giant now poised for much better times | |
04:08pm | PHILIPS NV : Barclays remains its Buy rating | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.13% | 19.11B | |
+8.61% | 219B | |
+7.02% | 183B | |
+10.90% | 133B | |
+24.95% | 108B | |
+0.27% | 63.06B | |
+12.76% | 52.02B | |
+3.96% | 48.2B | |
+0.29% | 40.37B | |
+13.56% | 39.35B |
- Stock Market
- Equities
- PHIA Stock
- News Philips NV
- Federal court enters agreement to restrict production of new Philips' sleep apnea devices